Pharmaceutical News

RSS

CHD Bioscience's lead product can help mitigate increasing threat of HAIs

According to a recent report issued by the Centers for Disease Control, every year more than two million people develop infections that are resistant to antibiotics. Specific healthcare-associated infections are classified as urgent threats and affect approximately 1.7 million people annually across the United States, leading to death in nearly 99,000 patients.

9 Oct 2013

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals.

9 Oct 2013

U.S. Army Grants QR Pharma, UCLA $3M To Test TBI Treatment

...

9 Oct 2013

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).

9 Oct 2013

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

A newly accessible vaccine against Japanese encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other Japanese encephalitis vaccines.

9 Oct 2013

Proveca signs agreement with EMA to develop Glycopyrronium drug for children with sialorrhoea

NORTH West pharmaceutical company Proveca Limited has reached a key agreement with the European Medicines Agency that will enable the development of a new drug designed for children and young people.

9 Oct 2013

DSP to set up anti-cancer drugs sales company in US

Dainippon Sumitomo Pharma Co., Ltd. (DSP) announced on October 9 that it has decided to establish an anti-cancer drugs sales company in the United States as a wholly-owned subsidiary of DSP's 100% owned U.S. holding company.

9 Oct 2013

Widespread prescription of levothyroxine medication may cause more harm than good

A study of patients in the United Kingdom suggests widespread prescribing of the medication levothyroxine sodium to boost thyroid function among patients with borderline high levels of the thyroid-stimulating hormone thyrotropin (a sign of low thyroid function), raising the possibility of overtreatment, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

9 Oct 2013

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons.

9 Oct 2013

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.

9 Oct 2013

Flumazenil reverses stress-triggered anxiety in methamphetamine dependant rats

SUNY Downstate Medical Center announced today that Sheryl Smith, PhD, professor of physiology and pharmacology, has published new findings demonstrating a reproducible pathology that may help shed light on anxiety and mood volatility in methamphetamine dependence.

9 Oct 2013

Healthcare providers report unaccompanied teens may not receive required vaccines

Healthcare providers report that older teens often go to the doctor without a parent or guardian, a new survey in the Journal of Adolescent Health reveals—and those teens may not get necessary vaccinations because there's no parent or guardian present to give consent.

9 Oct 2013

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Janssen Pharmaceuticals, Inc. announced today the acquisition of the investigational compound GSK2336805, an NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C, from an affiliate of GlaxoSmithKline plc.

9 Oct 2013

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

A new analysis of two HIV vaccine trials that involved pediatric patients shows that the investigational vaccines stimulated a critical immune response in infants born to HIV-infected mothers, researchers at Duke Medicine report.

9 Oct 2013

Study looks at attitudes toward drug use among high school seniors

High school seniors who frown upon the use of drugs are most likely to be female, nonsmokers or hold strong religious beliefs, according to a study- by Joseph Palamar of New York University. Palamar examines how teenagers' attitudes toward marijuana influenced their thoughts on the further use of other illicit drugs.

9 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

Report: States lax in taking steps to curb prescription drug abuse

The number of deaths attributed to the abuse of painkillers and other prescription drugs has risen sharply in recent years.

9 Oct 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

Ramsell partners with Alameda County to provide pharmacy benefits management services

Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management services to more than 900 low-income mental health patients.

9 Oct 2013

Pharmaceutical News

CHD Bioscience's lead product can help mitigate increasing threat of HAIs

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

U.S. Army Grants QR Pharma, UCLA $3M To Test TBI Treatment

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

Proveca signs agreement with EMA to develop Glycopyrronium drug for children with sialorrhoea

DSP to set up anti-cancer drugs sales company in US

Widespread prescription of levothyroxine medication may cause more harm than good

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Flumazenil reverses stress-triggered anxiety in methamphetamine dependant rats

Healthcare providers report unaccompanied teens may not receive required vaccines

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

Study looks at attitudes toward drug use among high school seniors

FMCNA encourages dialysis patients to get vaccinated against flu

Report: States lax in taking steps to curb prescription drug abuse

Bayer HealthCare receives FDA approval for Adempas tablets

Ramsell partners with Alameda County to provide pharmacy benefits management services

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News